Recordati SpA (REC) EUR0.125

Recordati Industria Chimica e Farmaceutica SpA is an Italy-based company operating in the pharmaceutical sector. The Company is engaged in the research, development, manufacture and marketing of pharmaceuticals, and its business includes two segments: Specialty & Primary Care and Rare Diseases. It promotes a range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The Company is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases.